
A biological response modifier, mixed bacterial vaccine zzso derived from zzso zzso and zzso zzso was used as a single agent in the treatment of 11 patients with zzso zzso zzso effect on zzso zzso production, plasma zzso zzso and tumor necrosis factor zzso levels was zzso Most patients' peripheral blood zzso cells continued to produce baseline to elevated levels of zzso in spite of age and disease zzso Several patients maintained moderate to high zzso zzso In general there was little correlation between zzso and zzso levels or with the response to zzso One of 11 patients had minor response, 1 of 11 had partial response, 4 of 11 had temporary stabilization of disease, and 5 of 11 had progressive zzso A patient with AIDS and zzso zzso experienced a dramatic improvement in performance status and disease zzso In all patients side effects occurred only following zzso and not zzso administration and included fever and zzso No adverse zzso zzso or zzso effects were zzso zzso is a zzso biological response modifier with modest activity in advanced human zzso 

